Member access

4-Traders Homepage  >  Shares  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote NATIONAL STOCK EXCHANGE OF INDIA
07/23/2014 07/24/2014 07/25/2014 07/28/2014 07/30/2014 Date
2492(c) 2481.1(c) 2481(c) 2481.05(c) 2494.5 Last
3 462 3 644 4 083 4 588 3 448 Volume
+0.89% -0.44% -0.00% 0.00% +0.54% Change
More quotes
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
08/12Earnings Release
Surperformance© rating of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More about the company
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Financials ( INR)
Sales 2014 27 948 M
EBIT 2014 6 915 M
Net income 2014 5 592 M
Finance 2014 22 211 M
Yield 2014 2,28%
Sales 2015 30 920 M
EBIT 2015 8 015 M
Net income 2015 6 527 M
Finance 2015 20 392 M
Yield 2015 2,34%
PER 2014 37,72
PER 2015 32,36
EV / Sales 2014 6,76x
EV / Sales 2015 6,17x
Capitalization 211 033 M
More Financials
Latest news on GLAXOSMITHKLINE PHARMACEUT
1d ago GLAXOSMITHKLINE : IN THE KNOW: Liberum Cuts Glaxo To 'Sell' As Worse On The Way
1d ago GLAXOSMITHKLINE : PRESS: Shanghai Trial For Glaxo Investigators Set For Aug 8 - ..
2d ago GLAXOSMITHKLINE : PRESS: Glaxo Has Option To Separate Consumer Healthcare Busine..
5d ago GLAXOSMITHKLINE : Glaxo pair face trial in China
5d ago GLAXOSMITHKLINE : Glaxo To "Thoroughly Investigate" Syria Misconduct Claims
5d ago GLAXOSMITHKLINE : Facing Bribery Allegations In Syria - Reuters (PRESS)
7d ago GLAXOSMITHKLINE : Lowers Earnings Guidance As Half-Year Profits Fall
07/22 PRESS : Lupin, US Firms Weighing Bids For Glaxo's Mature Drugs - Reuters
07/21 GLAXOSMITHKLINE : Business: Agenda: A suitable case for treatment: MAKING THE NE..
07/19 GLAXOSMITHKLINE : Agenda A suitable case for treatment: BY NICK FLETCHER: MAKING..
07/17 GLAXOSMITHKLINE : Glaxo Says Committee Recommends Trametinib/Dabrafenib Trial St..
07/17 GLAXOSMITHKLINE : PRESS: Glaxo Staff In China Were Caught Bribing Officials In 2..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
GlaxoSmithKline Pharmaceut : Income Statement Evolution
More Financials
EPS Revisions
GlaxoSmithKline Pharmaceut : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF